Challenges in CAR T-Cell Therapy for Lymphoma
Delve into the challenges of CAR T-cell therapy access and explore the biology behind treatment responses and relapses in lymphoma patients.
Source: onclive.com
Stay updated with breaking news from Antigen Escape. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Delve into the challenges of CAR T-cell therapy access and explore the biology behind treatment responses and relapses in lymphoma patients.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are part of an international team of scientists who identified mechanisms by which some multiple myelomas become resistant to initially effective T-cell therapies.